The HHS and FDA have launched a review of abortion pill mifepristone after a disputed safety study, sparking backlash from abortion rights advocates.
Breakdown
- HHS Secretary Robert F. Kennedy Jr. announced an FDA review of abortion pills.
- The review could lead to new restrictions on abortion medication. 11s
- Mifepristone is used in nearly two-thirds of abortions nationwide. 16s
- Republicans have pushed for changes to FDA rules on Mifepristone. 21s
- Abortion rights advocates say restrictions would further limit access where bans exist. 26s